Uslu et al. found that CSPG4-targeting CAR-NKT cells produced noticeably fewer CRS-related cytokines (such as IL-6) while exhibiting tumor cytotoxicity comparable to that of CAR-T cells [411]. The gene discussed is IL6; the disease is congenital rubella syndrome.